Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Iatrogenic celiac and hepatic artery dissections during intra-arterial regional tumor therapies: a 16-year retrospective review.

Alexander ES, Nadolski GJ, Soulen MC, Stavropoulos SW, Hunt SJ, Gade TP, Itkin M, Shamimi-Noori S.

Abdom Radiol (NY). 2019 Oct;44(10):3480-3485. doi: 10.1007/s00261-019-02203-z.

PMID:
31471705
2.

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers.

Haas AR, Tanyi JL, O'Hara MH, Gladney WL, Lacey SF, Torigian DA, Soulen MC, Tian L, McGarvey M, Nelson AM, Farabaugh CS, Moon E, Levine BL, Melenhorst JJ, Plesa G, June CH, Albelda SM, Beatty GL.

Mol Ther. 2019 Jul 30. pii: S1525-0016(19)30328-4. doi: 10.1016/j.ymthe.2019.07.015. [Epub ahead of print]

PMID:
31420241
3.

Radioembolization-Induced Chronic Hepatotoxicity: A Single-Center Cohort Analysis.

Currie BM, Hoteit MA, Ben-Josef E, Nadolski GJ, Soulen MC.

J Vasc Interv Radiol. 2019 Jul 26. pii: S1051-0443(19)30547-0. doi: 10.1016/j.jvir.2019.06.003. [Epub ahead of print]

PMID:
31353191
4.

Establishment of hepatocellular carcinoma patient-derived xenografts from image-guided percutaneous biopsies.

Tischfield DJ, Ackerman D, Noji M, Chen JX, Johnson O, Perkons NR, Nadolski GJ, Hunt SJ, Soulen MC, Furth EE, Gade TP.

Sci Rep. 2019 Jul 22;9(1):10546. doi: 10.1038/s41598-019-47104-9.

5.

A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.

Wu J, Chang J, Bai HX, Su C, Zhang PJ, Karakousis G, Reddy S, Hunt S, Soulen MC, Stavropoulos SW, Zhang Z.

J Vasc Interv Radiol. 2019 Jul;30(7):1027-1033.e3. doi: 10.1016/j.jvir.2019.01.029. Epub 2019 Jun 5.

PMID:
31176590
6.

Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study.

Habibollahi P, Shamchi SP, Choi JM, Gade TP, Stavropoulos SW, Hunt SJ, Dagli M, Sudheendra D, Mondschein JI, Soulen MC, Nadolski GJ.

J Vasc Interv Radiol. 2019 Mar;30(3):323-329. doi: 10.1016/j.jvir.2018.11.037.

PMID:
30819472
7.

Complication rates of percutaneous biliary drainage in the presence of ascites.

Patel V, McLaughlin SW, Shlansky-Goldberg R, Gade T, Bonshock R, Hunt S, Stavropoulos SW, Trerotola SO, Soulen MC, Nadolski G.

Abdom Radiol (NY). 2019 May;44(5):1901-1906. doi: 10.1007/s00261-019-01916-5.

PMID:
30725128
8.

Impact of a Monthly Compliance Review on Interventional Radiology Adverse Event Reporting.

Dagli MS, Soulen MC, McGinn C, Mondschein JI, Clark TWI, Sudheendra D, Trerotola SO.

J Am Coll Radiol. 2019 Jan;16(1):73-78. doi: 10.1016/j.jacr.2018.09.049. Epub 2018 Nov 22.

PMID:
30470556
9.

Electrolytic ablation enables cancer cell targeting through pH modulation.

Perkons NR, Stein EJ, Nwaezeapu C, Wildenberg JC, Saleh K, Itkin-Ofer R, Ackerman D, Soulen MC, Hunt SJ, Nadolski GJ, Gade TP.

Commun Biol. 2018 May 17;1:48. doi: 10.1038/s42003-018-0047-1. eCollection 2018.

10.

Definitive locoregional therapy (LRT) versus bridging LRT and liver transplantation with wait-and-not-treat approach for very early stage hepatocellular carcinoma.

Habibollahi P, Hunt S, Bitterman T, Gade TP, Soulen MC, Nadolski G.

Diagn Interv Radiol. 2018 Jul;24(4):213-218. doi: 10.5152/dir.2018.17418.

11.

Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors.

Soulen MC, van Houten D, Teitelbaum UR, Damjanov N, Cengel KA, Metz DC.

Pancreas. 2018 Sep;47(8):980-984. doi: 10.1097/MPA.0000000000001115.

PMID:
30028446
12.
13.

90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.

Devulapalli KK, Fidelman N, Soulen MC, Miller M, Johnson MS, Addo E, El-Haddad G, Nutting C, Morrison J, Farsad K, Lokken RP, Gaba RC, Fleming J, Brown DB, Kwan SW, Rose SC, Pennycooke KA, Liu DM, White SB, Gandhi R, Lazar AA, Kerlan RK Jr.

Radiology. 2018 Sep;288(3):774-781. doi: 10.1148/radiol.2018170962. Epub 2018 May 8.

PMID:
29737954
14.

Small Renal Masses: Challenges for the Radiologist.

Soulen MC.

Radiology. 2018 Jul;288(1):91-92. doi: 10.1148/radiol.2018180602. Epub 2018 May 8. No abstract available.

PMID:
29737952
15.

Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.

Beatty GL, O'Hara MH, Lacey SF, Torigian DA, Nazimuddin F, Chen F, Kulikovskaya IM, Soulen MC, McGarvey M, Nelson AM, Gladney WL, Levine BL, Melenhorst JJ, Plesa G, June CH.

Gastroenterology. 2018 Jul;155(1):29-32. doi: 10.1053/j.gastro.2018.03.029. Epub 2018 Mar 20.

16.

Combined chemoembolization and thermal ablation for the treatment of metastases to the liver.

Alexander ES, Mick R, Nadolski GJ, Mondschein JI, Stavropoulos SW, Soulen MC.

Abdom Radiol (NY). 2018 Oct;43(10):2859-2867. doi: 10.1007/s00261-018-1536-x.

PMID:
29500644
17.

Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.

Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, Gibbs P, Knuth A, Sangro B, Soulen MC, Pittari G, Sharma RA.

J Gastrointest Oncol. 2017 Dec;8(6):1079-1099. doi: 10.21037/jgo.2017.09.10. Review.

18.

Combination of Neoadjuvant Transcatheter Arterial Chemoembolization and Orthotopic Liver Transplantation for the Treatment of Cirrhotomimetic Hepatocellular Carcinoma.

Habibollahi P, Shamchi SP, Tondon R, Ecker BL, Gade TP, Hunt S, Soulen MC, Furth EE, Levine MH, Nadolski G.

J Vasc Interv Radiol. 2018 Feb;29(2):237-243. doi: 10.1016/j.jvir.2017.09.008. Epub 2017 Dec 6.

PMID:
29221923
19.

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O'Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR.

J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12. No abstract available.

20.

Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis.

Katona BW, Roccaro GA, Soulen MC, Yang YX, Bennett BJ, Riff BP, Glynn RA, Wild D, Nicolas GP, Pryma DA, Teitelbaum UR, Metz DC.

Pancreas. 2017 Oct;46(9):1121-1126. doi: 10.1097/MPA.0000000000000919.

21.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, Kunz PL, O'Dorisio TM, Salem R, Segelov E, Howe JR, Pommier RF, Brendtro K, Bashir MA, Singh S, Soulen MC, Tang L, Zacks JS, Yao JC, Bergsland EK.

Pancreas. 2017 Jul;46(6):707-714. doi: 10.1097/MPA.0000000000000850. Review.

22.

Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE.

Currie BM, Soulen MC.

Semin Intervent Radiol. 2017 Jun;34(2):92-100. doi: 10.1055/s-0037-1602591. Epub 2017 Jun 1. Review.

23.

Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes.

Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ.

World J Hepatol. 2017 Apr 28;9(12):603-612. doi: 10.4254/wjh.v9.i12.603.

24.

Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization.

Kiefer RM, Hunt SJ, Pulido S, Pickup S, Furth EE, Soulen MC, Nadolski GJ, Gade TP.

J Vasc Interv Radiol. 2017 Jul;28(7):1043-1050.e2. doi: 10.1016/j.jvir.2017.03.037. Epub 2017 May 9.

25.

Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma.

Gade TPF, Tucker E, Nakazawa MS, Hunt SJ, Wong W, Krock B, Weber CN, Nadolski GJ, Clark TWI, Soulen MC, Furth EE, Winkler JD, Amaravadi RK, Simon MC.

Radiology. 2017 Jun;283(3):702-710. doi: 10.1148/radiol.2017160728. Epub 2017 Mar 2.

26.

Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis.

Chao C, Stavropoulos SW, Mondschein JI, Dagli M, Sudheendra D, Nadolski G, Soulen MC.

Clin Nucl Med. 2017 Mar;42(3):176-179. doi: 10.1097/RLU.0000000000001532.

PMID:
28072623
27.

Liver Metastases From Noncolorectal Malignancies (Neuroendocrine Tumor, Sarcoma, Melanoma, Breast).

Alexander ES, Soulen MC.

Cancer J. 2016 Nov/Dec;22(6):381-386. Review.

PMID:
27870680
28.

Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.

Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC.

Cardiovasc Intervent Radiol. 2017 Jan;40(1):69-80. doi: 10.1007/s00270-016-1478-z. Epub 2016 Oct 13.

PMID:
27738818
29.

Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.

Chen JX, Maass D, Guzzo TJ, Bruce Malkowicz S, Wein AJ, Soulen MC, Clark TWI, Nadolski GJ, William Stavropoulos S.

J Vasc Interv Radiol. 2016 Sep;27(9):1397-1406. doi: 10.1016/j.jvir.2016.03.038. Epub 2016 May 24.

PMID:
27234485
30.

Percutaneous biliary drainage effectively lowers serum bilirubin to permit chemotherapy treatment.

Levy JL, Sudheendra D, Dagli M, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Teitelbaum U, Mick R, Soulen MC.

Abdom Radiol (NY). 2016 Feb;41(2):317-23. doi: 10.1007/s00261-015-0580-z.

PMID:
26867914
31.

Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.

Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF.

Hepatology. 2016 Jul;64(1):106-16. doi: 10.1002/hep.28453. Epub 2016 Mar 7. Review.

PMID:
26765068
32.

Percutaneous Renal Cryoablation: Short-Axis Ice-Ball Margin as a Predictor of Outcome.

Ge BH, Guzzo TJ, Nadolski GJ, Soulen MC, Clark TW, Malkowicz SB, Wein AJ, Hunt SJ, Stavropoulos SW.

J Vasc Interv Radiol. 2016 Mar;27(3):403-9. doi: 10.1016/j.jvir.2015.11.035. Epub 2016 Jan 2.

PMID:
26755344
33.

Complication and Readmission Rates following Same-Day Discharge after Percutaneous Renal Tumor Ablation.

Chen JX, Guzzo TJ, Malkowicz SB, Soulen MC, Wein AJ, Clark TW, Nadolski GJ, Stavropoulos SW.

J Vasc Interv Radiol. 2016 Jan;27(1):80-6. doi: 10.1016/j.jvir.2015.09.007. Epub 2015 Nov 4.

PMID:
26547122
34.

Recurrent Bleeding, Survival, and Longitudinal Pulmonary Function following Bronchial Artery Embolization for Hemoptysis in a U.S. Adult Population.

Tom LM, Palevsky HI, Holsclaw DS, Trerotola SO, Dagli M, Mondschein JI, Stavropoulos SW, Soulen MC, Clark TW.

J Vasc Interv Radiol. 2015 Dec;26(12):1806-13.e1. doi: 10.1016/j.jvir.2015.08.019. Epub 2015 Oct 9.

PMID:
26481824
35.

Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.

de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC.

Cardiovasc Intervent Radiol. 2016 Mar;39(3):334-43. doi: 10.1007/s00270-015-1208-y. Epub 2015 Sep 21. Review.

PMID:
26390875
36.

Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors.

Riff BP, Yang YX, Soulen MC, Pryma DA, Bennett B, Wild D, Nicolas G, Teitelbaum UR, Metz DC.

Clin Nucl Med. 2015 Nov;40(11):845-50. doi: 10.1097/RLU.0000000000000935.

PMID:
26284763
37.

Magnetic Resonance-Monitored Coaxial Electrochemical Ablation--Preliminary Evaluation of Technical Feasibility.

Ge BH, Weber CN, Wildenberg JC, Nadolski GJ, Gade TP, Hunt SJ, Soulen MC, Itkin M.

J Vasc Interv Radiol. 2015 Aug;26(8):1238-46. doi: 10.1016/j.jvir.2015.05.015.

PMID:
26210247
38.

Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts.

Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC.

J Vasc Interv Radiol. 2015 Sep;26(9):1257-65; quiz 1265. doi: 10.1016/j.jvir.2015.04.005. Epub 2015 May 16.

PMID:
25990133
39.

Long-term outcomes of a benign biliary stricture protocol.

DePietro DM, Shlansky-Goldberg RD, Soulen MC, Stavropoulos SW, Mondschein JI, Dagli MS, Itkin M, Clark TW, Trerotola SO.

J Vasc Interv Radiol. 2015 Jul;26(7):1032-9. doi: 10.1016/j.jvir.2015.03.002. Epub 2015 Apr 15.

PMID:
25890686
40.

Effect of central venous angioplasty on hemodialysis access circuit flow: prospective study of 25 symptomatic patients.

Yan Y, Sudheendra D, Dagli MS, William Stavropoulos S, Clark TW, Soulen MC, Mondschein JI, Shlansky-Goldberg RD, Trerotola SO.

J Vasc Interv Radiol. 2015 Jul;26(7):984-91. doi: 10.1016/j.jvir.2015.03.005. Epub 2015 Apr 15.

PMID:
25890685
41.

Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma.

Gade TP, Hunt SJ, Harrison N, Nadolski GJ, Weber C, Pickup S, Furth EE, Schnall MD, Soulen MC, Celeste Simon M.

J Vasc Interv Radiol. 2015 Aug;26(8):1229-37. doi: 10.1016/j.jvir.2015.02.006. Epub 2015 Apr 8.

42.

Antivascular ultrasound therapy: magnetic resonance imaging validation and activation of the immune response in murine melanoma.

Hunt SJ, Gade T, Soulen MC, Pickup S, Sehgal CM.

J Ultrasound Med. 2015 Feb;34(2):275-87. doi: 10.7863/ultra.34.2.275.

PMID:
25614401
43.

A patient with acute kidney pain and high blood pressure.

Cohen DL, Soulen MC.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):696-702. doi: 10.2215/CJN.10171014. Epub 2015 Jan 12.

44.

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD 3rd, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-Guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe.

J Vasc Interv Radiol. 2014 Nov;25(11):1691-705.e4. doi: 10.1016/j.jvir.2014.08.027. Epub 2014 Oct 23.

PMID:
25442132
45.

Risk of liver abscess formation in patients with prior biliary intervention following yttrium-90 radioembolization.

Cholapranee A, van Houten D, Deitrick G, Dagli M, Sudheendra D, Mondschein JI, Soulen MC.

Cardiovasc Intervent Radiol. 2015 Apr;38(2):397-400. doi: 10.1007/s00270-014-0947-5. Epub 2014 Jul 3.

PMID:
24989145
46.

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD 3rd, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology,; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe.

Radiology. 2014 Oct;273(1):241-60. doi: 10.1148/radiol.14132958. Epub 2014 Jun 13.

47.

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

Beatty GL, Haas AR, Maus MV, Torigian DA, Soulen MC, Plesa G, Chew A, Zhao Y, Levine BL, Albelda SM, Kalos M, June CH.

Cancer Immunol Res. 2014 Feb;2(2):112-20. doi: 10.1158/2326-6066.CIR-13-0170. Erratum in: Cancer Immunol Res. 2015 Feb;3(2):217.

48.

Combining locoregional therapies in the treatment of hepatocellular carcinoma.

Higgins MC, Soulen MC.

Semin Intervent Radiol. 2013 Mar;30(1):74-81. doi: 10.1055/s-0033-1333656. Review.

49.

Outcomes of percutaneous interventions in transposed hemodialysis fistulas compared with nontransposed fistulas and grafts.

Yan Y, Clark TW, Mondschein JI, Shlansky-Goldberg RD, Dagli MS, Soulen MC, Stavropoulos SW, Sudheendra D, Mantell MP, Cohen RD, Kobrin S, Chittams JL, Trerotola SO.

J Vasc Interv Radiol. 2013 Dec;24(12):1765-72; quiz 1773.

PMID:
24409470
50.

Peripherally inserted central catheter thrombosis--reverse tapered versus nontapered catheters: a randomized controlled study.

Itkin M, Mondshein JI, Stavropoulos SW, Shlansky-Goldberg RD, Soulen MC, Trerotola SO.

J Vasc Interv Radiol. 2014 Jan;25(1):85-91.e1. doi: 10.1016/j.jvir.2013.10.009. Epub 2013 Nov 21.

PMID:
24268631

Supplemental Content

Loading ...
Support Center